Is health technology separating patients, providers?

While popular health tracking applications and smart watches can screen serious and sometimes deadly problems including atrial fibrillation and sleep apnea, diagnosis and subsequent treatment can only be provided by a physician. The only caveat? Patients do not like going to the doctor. 

To mitigate the problem, digital health companies may need to partner with providers by offering services within clinics and hospitals to provide the type of experience patients want.

"All the things done well by digital health—they're simple, fun, visual with great user experience—are still missing from most clinical visits—so it remains pretty unpleasant to be a patient," said Jeffrey Wessler, a cardiology fellow at Columbia University Medical Center and the founder of a digital health company called Heartbeat. "To me, this gap gets closed by bringing the clinical experience up to the same standards as our digital health solutions."

To read the story, click the link below.

""

As a senior news writer for TriMed, Subrata covers cardiology, clinical innovation and healthcare business. She has a master’s degree in communication management and 12 years of experience in journalism and public relations.

Around the web

The tirzepatide shortage that first began in 2022 has been resolved. Drug companies distributing compounded versions of the popular drug now have two to three more months to distribute their remaining supply.

The 24 members of the House Task Force on AI—12 reps from each party—have posted a 253-page report detailing their bipartisan vision for encouraging innovation while minimizing risks. 

Merck sent Hansoh Pharma, a Chinese biopharmaceutical company, an upfront payment of $112 million to license a new investigational GLP-1 receptor agonist. There could be many more payments to come if certain milestones are met.